FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Medisca Bimatoprost powder Recall

Bimatoprost powder, Bulk Ingredient, a) 5g (NDC 38779-3066-03), b) 1g (NDC 38779-3066-0…

Medisca Inc. · Irving, TX

Risk level
Class II
Reported by FDA
Apr 30, 2025
Recall ID
D-0386-2025
Check your lot numberHow we source this data

Summary

Medisca recalled Bimatoprost powder starting Mar 31, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0386-2025 on Apr 30, 2025. Reason: CGMP Deviations. Status: Terminated.

Why it was recalled

CGMP Deviations

Product description

Bimatoprost powder, Bulk Ingredient, a) 5g (NDC 38779-3066-03), b) 1g (NDC 38779-3066-06), c) 1g (NDC 38779-3066-09) drums, Medisca, Plattsburgh, NY

Lot numbers, UPCs & expiration codes

Lot# 201727/A/B/C/D/E & F, exp. date 05/31/2027, product # 3066 Lot# 208475/A/B/D/E/G/H & I, exp. date 09/30/2028, product # 3066

Where it was sold

US Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0386-2025
Classification
Class II
Status
Terminated
Recall initiated
Mar 31, 2025
FDA report date
Apr 30, 2025
Quantity
161.6 grams
Recall type
Voluntary: Firm initiated
Recalling firm
Medisca Inc.

Original FDA data

Every field from FDA enforcement report D-0386-2025, exactly as published.

Show all FDA fields
City
Irving
State
TX
Status
Terminated
Country
United States
Event ID
96600
Address
6641 N Belt Line Rd Ste 130
Code information
Lot# 201727/A/B/C/D/E & F, exp. date 05/31/2027, product # 3066 Lot# 208475/A/B/D/E/G/H & I, exp. date 09/30/2028, product # 3066
Postal code
75063-6001
Report date
Apr 30, 2025
Product type
Drugs
Recall number
D-0386-2025
Classification
Class II
Recalling firm
Medisca Inc.
Product quantity
161.6 grams
Termination date
Oct 10, 2025
Reason for recall
CGMP Deviations
Voluntary / mandated
Voluntary: Firm initiated
Product description
Bimatoprost powder, Bulk Ingredient, a) 5g (NDC 38779-3066-03), b) 1g (NDC 38779-3066-06), c) 1g (NDC 38779-3066-09) drums, Medisca, Plattsburgh, NY
Distribution pattern
US Nationwide.
Recall initiation date
Mar 31, 2025
Center classification date
Apr 21, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0386-2025, published Apr 30, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls